U.S. market Closed. Opens in 7 hours 36 minutes

RMED | Ra Medical Systems, Inc. Stock Overview

(Stock Exchange: AMEX)
Day's Range 0.5200 - 0.5940
52 Week Range 0.4808 - 11.14
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 74,500
Average Volume 290,931
Shares Outstanding 6,461,228
Market Cap 3,837,969
Sector Healthcare
Industry Medical - Devices
IPO Date 2018-09-27
Valuation
Profitability
Growth
Health
P/E Ratio -0.02
Forward P/E Ratio N/A
EPS -35.78
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 14
Country USA
Website RMED
Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.
RMED's peers: AEMD, BBLG, MYO, NAOV, NSPR, NURO, NUWE, RSLS, SINT, TIVC
*Chart delayed
Analyzing fundamentals for RMED we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see RMED Fundamentals page.

Watching at RMED technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on RMED Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙